Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
about
Plasmodium falciparum Plasmepsin 2 Duplications, West AfricaEfficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line AntimalarialsLiver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study
P2860
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@en
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@nl
type
label
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@en
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@nl
prefLabel
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@en
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@nl
P2860
P1433
P1476
Pyronaridine-artesunate or dih ...... controlled, phase 3b/4 trial.
@en
P2093
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
P2860
P304
P356
10.1016/S0140-6736(18)30291-5
P407
P577
2018-03-29T00:00:00Z